Skip to main content

What the FDA labels say about taking them together

Eliglustat and quinidine

Eliglustat's FDA label of March 3, 2024 names quinidine in its warnings and precautions section; the quinidine label PlainMeds reads does not name eliglustat. The eliglustat label: “Avoid use of CERDELGA in patients with: pre-existing cardiac disease long QT syndrome in combination with Class IA or Class III antiarrhythmic medications”

Check it at the source: the eliglustat FDA label on DailyMed (effective March 3, 2024, Genzyme Corporation); the quinidine FDA label on DailyMed (effective February 1, 2018, Sun Pharmaceutical Industries, Inc.).

What does the eliglustat label say about quinidine?

Eliglustat label, warnings and precautions

Avoid use of CERDELGA in patients with: pre-existing cardiac disease (congestive heart failure, recent acute myocardial infarction, bradycardia, heart block, ventricular arrhythmia) long QT syndrome in combination with Class IA (e.g., quinidine, procainamide) or Class III (e.g., amiodarone, sotalol) antiarrhythmic medications [see Clinical Pharmacology (12.2) ]

Source: FDA drug label (Cerdelga), Genzyme Corporation, effective March 3, 2024 (SPL set 819f828a-b888-4e46-83fc-94d774a28a83), via openFDA; the full label on DailyMed

What does the quinidine label say about eliglustat?

Quinidine's label (effective February 1, 2018) does not name eliglustat in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Quinidine Gluconate), Sun Pharmaceutical Industries, Inc., effective February 1, 2018 (SPL set 5023f053-fcc4-4c2c-aa59-9ec198ad185e), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Eliglustat generic labelers
4Quinidine generic labelers
EliglustatQuinidine
Labeled forn/aAtrial fibrillation
Boxed warningNoYes
Pharmacy cost (NADAC)n/a$4.92 per tablet 324 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?